If you start with 1 primary outcome and 17 secondary outcomes but are allowed to change the primary outcome to whichever of the secondary outcomes you like late, late in the trial, then there'd be a 1-0.95^18 = 60% chance that the chicken soup would show a "significant effect" ...just like remdesivir did.
I suspect leronlimab will show p < 0.05 on primary outcome and most of the secondary outcomes.
You may be right. There have been studies that traditional Jewish chicken soup made with chicken feet can reduce the effects of the common cold due to the cartilage.